Susquehanna International Group
ABBV icon

Susquehanna International Group’s AbbVie ABBV Stock Holding History

Susquehanna International Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$521M Sell
2,394,600
-137,500
-5% -$30.5M 0.06% 253
2025
Q4 		$579M Sell
2,532,100
-529,600
-17% -$121M 0.07% 226
2025
Q3 		$709M Buy
3,061,700
+1,070,900
+54% +$218M 0.08% 192
2025
Q2 		$370M Sell
1,990,800
-455,500
-19% -$84.7M 0.05% 283
2025
Q1 		$513M Sell
2,446,300
-148,800
-6% -$28.9M 0.09% 170
2024
Q4 		$461M Buy
2,595,100
+655,600
+34% +$121M 0.07% 213
2024
Q3 		$383M Buy
1,939,500
+317,200
+20% +$59.2M 0.07% 240
2024
Q2 		$278M Sell
1,622,300
-247,800
-13% -$41M 0.05% 267
2024
Q1 		$341M Sell
1,870,100
-1,013,700
-35% -$175M 0.06% 257
2023
Q4 		$447M Buy
2,883,800
+176,200
+7% +$25.7M 0.09% 183
2023
Q3 		$404M Sell
2,707,600
-215,800
-7% -$31.7M 0.08% 175
2023
Q2 		$394M Buy
2,923,400
+1,499,100
+105% +$220M 0.08% 185
2023
Q1 		$227M Sell
1,424,300
-1,190,500
-46% -$182M 0.05% 313
2022
Q4 		$423M Buy
2,614,800
+586,400
+29% +$89.9M 0.11% 155
2022
Q3 		$272M Sell
2,028,400
-363,200
-15% -$52.1M 0.07% 213
2022
Q2 		$366M Buy
2,391,600
+626,000
+35% +$95.7M 0.09% 163
2022
Q1 		$286M Sell
1,765,600
-1,663,600
-49% -$242M 0.05% 297
2021
Q4 		$464M Sell
3,429,200
-951,100
-22% -$112M 0.07% 219
2021
Q3 		$473M Sell
4,380,300
-349,700
-7% -$40M 0.06% 250
2021
Q2 		$533M Buy
4,730,000
+835,400
+21% +$94.1M 0.07% 215
2021
Q1 		$421M Sell
3,894,600
-1,578,400
-29% -$169M 0.07% 249
2020
Q4 		$586M Sell
5,473,000
-292,700
-5% -$28.1M 0.1% 154
2020
Q3 		$505M Buy
5,765,700
+255,600
+5% +$24.1M 0.1% 149
2020
Q2 		$541M Sell
5,510,100
-479,300
-8% -$42.2M 0.13% 115
2020
Q1 		$456M Buy
5,989,400
+1,311,400
+28% +$112M 0.15% 109
2019
Q4 		$414M Sell
4,678,000
-457,800
-9% -$38M 0.12% 131
2019
Q3 		$389M Buy
5,135,800
+1,345,500
+35% +$92.2M 0.13% 127
2019
Q2 		$276M Buy
3,790,300
+1,370,500
+57% +$108M 0.1% 164
2019
Q1 		$195M Sell
2,419,800
-783,600
-24% -$64.1M 0.08% 204
2018
Q4 		$295M Sell
3,203,400
-358,100
-10% -$31.5M 0.12% 143
2018
Q3 		$337M Sell
3,561,500
-522,400
-13% -$49.5M 0.11% 138
2018
Q2 		$378M Buy
4,083,900
+831,900
+26% +$81.2M 0.13% 115
2018
Q1 		$308M Buy
3,252,000
+799,400
+33% +$87.8M 0.11% 142
2017
Q4 		$237M Buy
2,452,600
+708,400
+41% +$66.8M 0.08% 208
2017
Q3 		$155M Sell
1,744,200
-214,100
-11% -$16.3M 0.06% 262
2017
Q2 		$142M Buy
1,958,300
+598,400
+44% +$40.2M 0.06% 254
2017
Q1 		$88.6M Sell
1,359,900
-553,600
-29% -$34.8M 0.04% 371
2016
Q4 		$120M Buy
1,913,500
+462,900
+32% +$28.3M 0.06% 281
2016
Q3 		$91.5M Sell
1,450,600
-735,500
-34% -$47.6M 0.04% 344
2016
Q2 		$135M Sell
2,186,100
-988,200
-31% -$60.2M 0.07% 231
2016
Q1 		$181M Sell
3,174,300
-765,900
-19% -$42.7M 0.1% 165
2015
Q4 		$233M Sell
3,940,200
-1,407,900
-26% -$81.1M 0.11% 160
2015
Q3 		$291M Buy
5,348,100
+441,200
+9% +$28.7M 0.13% 135
2015
Q2 		$330M Buy
4,906,900
+936,400
+24% +$61.1M 0.14% 110
2015
Q1 		$232M Buy
3,970,500
+1,460,700
+58% +$88.2M 0.11% 164
2014
Q4 		$164M Buy
2,509,800
+1,102,300
+78% +$69.5M 0.07% 271
2014
Q3 		$81.3M Buy
1,407,500
+302,300
+27% +$16.8M 0.03% 497
2014
Q2 		$62.4M Sell
1,105,200
-81,500
-7% -$4.28M 0.03% 585
2014
Q1 		$61M Buy
1,186,700
+104,600
+10% +$5.29M 0.03% 532
2013
Q4 		$57.1M Buy
1,082,100
+522,400
+93% +$25.7M 0.03% 587
2013
Q3 		$25M Sell
559,700
-208,800
-27% -$9.26M 0.01% 1047
2013
Q2 		$31.8M Buy
+768,500
New +$33.6M 0.02% 792

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Susquehanna International Group's ABBV Position: Q1 2026 in Review

Susquehanna International Group increased its AbbVie (ABBV) stake by 51% in Q1 2026, buying an estimated $32.2M and bringing the position to 431,015 shares worth $93.7M. The position accounts for 0.01% of the portfolio, ranked #873.

Susquehanna International Group first reported a position in ABBV in Q2 2013 and has held it in 49 quarters since. The position peaked at $349M in Q4 2021. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Susquehanna International Group held 431,015 shares of AbbVie worth $93.7M as of Q1 2026.
  • Susquehanna International Group bought 145,084 AbbVie shares in Q1 2026, an estimated $32.2M.
  • AbbVie made up 0.01% of Susquehanna International Group's portfolio in Q1 2026, its #873 holding.
  • Susquehanna International Group first reported a position in AbbVie in Q2 2013 and has held it in 49 quarters since.
  • Susquehanna International Group's AbbVie position peaked at $349M in Q4 2021.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.